These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 29649621

  • 21. Glycyrrhizic acid Attenuates Neuroinflammation and Oxidative Stress in Rotenone Model of Parkinson's Disease.
    Ojha S, Javed H, Azimullah S, Abul Khair SB, Haque ME.
    Neurotox Res; 2016 Feb; 29(2):275-87. PubMed ID: 26607911
    [Abstract] [Full Text] [Related]

  • 22. DJ-1 deficiency in astrocytes selectively enhances mitochondrial Complex I inhibitor-induced neurotoxicity.
    Mullett SJ, Hinkle DA.
    J Neurochem; 2011 May; 117(3):375-87. PubMed ID: 21219333
    [Abstract] [Full Text] [Related]

  • 23. Rotenone impairs autophagic flux and lysosomal functions in Parkinson's disease.
    Wu F, Xu HD, Guan JJ, Hou YS, Gu JH, Zhen XC, Qin ZH.
    Neuroscience; 2015 Jan 22; 284():900-911. PubMed ID: 25446361
    [Abstract] [Full Text] [Related]

  • 24. shRNA targeting α-synuclein prevents neurodegeneration in a Parkinson's disease model.
    Zharikov AD, Cannon JR, Tapias V, Bai Q, Horowitz MP, Shah V, El Ayadi A, Hastings TG, Greenamyre JT, Burton EA.
    J Clin Invest; 2015 Jul 01; 125(7):2721-35. PubMed ID: 26075822
    [Abstract] [Full Text] [Related]

  • 25. DJ-1 regulating PI3K-Nrf2 signaling plays a significant role in bibenzyl compound 20C-mediated neuroprotection against rotenone-induced oxidative insult.
    Zhang XL, Yuan YH, Shao QH, Wang ZZ, Zhu CG, Shi JG, Ma KL, Yan X, Chen NH.
    Toxicol Lett; 2017 Apr 05; 271():74-83. PubMed ID: 28245986
    [Abstract] [Full Text] [Related]

  • 26. Soluble epoxide hydrolase inhibitor, APAU, protects dopaminergic neurons against rotenone induced neurotoxicity: Implications for Parkinson's disease.
    Lakkappa N, Krishnamurthy PT, M D P, Hammock BD, Hwang SH.
    Neurotoxicology; 2019 Jan 05; 70():135-145. PubMed ID: 30472438
    [Abstract] [Full Text] [Related]

  • 27. Intranigral infusion of interleukin-1beta activates astrocytes and protects from subsequent 6-hydroxydopamine neurotoxicity.
    Saura J, Parés M, Bové J, Pezzi S, Alberch J, Marin C, Tolosa E, Martí MJ.
    J Neurochem; 2003 May 05; 85(3):651-61. PubMed ID: 12694391
    [Abstract] [Full Text] [Related]

  • 28. Cinnamon treatment upregulates neuroprotective proteins Parkin and DJ-1 and protects dopaminergic neurons in a mouse model of Parkinson's disease.
    Khasnavis S, Pahan K.
    J Neuroimmune Pharmacol; 2014 Sep 05; 9(4):569-81. PubMed ID: 24946862
    [Abstract] [Full Text] [Related]

  • 29. Neuroprotective efficacy of the glucocorticoid receptor modulator PT150 in the rotenone mouse model of Parkinson's disease.
    Latham AS, Rocha SM, McDermott CP, Reigan P, Slayden RA, Tjalkens RB.
    Neurotoxicology; 2024 Jul 05; 103():320-334. PubMed ID: 38960072
    [Abstract] [Full Text] [Related]

  • 30. Enhanced sensitivity of dopaminergic neurons to rotenone-induced toxicity with aging.
    Phinney AL, Andringa G, Bol JG, Wolters ECh, van Muiswinkel FL, van Dam AM, Drukarch B.
    Parkinsonism Relat Disord; 2006 May 05; 12(4):228-38. PubMed ID: 16488175
    [Abstract] [Full Text] [Related]

  • 31. Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation.
    Sherer TB, Kim JH, Betarbet R, Greenamyre JT.
    Exp Neurol; 2003 Jan 05; 179(1):9-16. PubMed ID: 12504863
    [Abstract] [Full Text] [Related]

  • 32. Rotenone induces regionally distinct α-synuclein protein aggregation and activation of glia prior to loss of dopaminergic neurons in C57Bl/6 mice.
    Rocha SM, Bantle CM, Aboellail T, Chatterjee D, Smeyne RJ, Tjalkens RB.
    Neurobiol Dis; 2022 Jun 01; 167():105685. PubMed ID: 35257879
    [Abstract] [Full Text] [Related]

  • 33. Neuroprotective effect of the antiparkinsonian drug pramipexole against nigrostriatal dopaminergic degeneration in rotenone-treated mice.
    Inden M, Kitamura Y, Tamaki A, Yanagida T, Shibaike T, Yamamoto A, Takata K, Yasui H, Taira T, Ariga H, Taniguchi T.
    Neurochem Int; 2009 Dec 01; 55(8):760-7. PubMed ID: 19647776
    [Abstract] [Full Text] [Related]

  • 34. Neuroprotective potential of ferulic acid in the rotenone model of Parkinson's disease.
    Ojha S, Javed H, Azimullah S, Abul Khair SB, Haque ME.
    Drug Des Devel Ther; 2015 Dec 01; 9():5499-510. PubMed ID: 26504373
    [Abstract] [Full Text] [Related]

  • 35. Selective microglial activation in the rat rotenone model of Parkinson's disease.
    Sherer TB, Betarbet R, Kim JH, Greenamyre JT.
    Neurosci Lett; 2003 May 01; 341(2):87-90. PubMed ID: 12686372
    [Abstract] [Full Text] [Related]

  • 36. DJ-1 protein protects dopaminergic neurons against 6-OHDA/MG-132-induced neurotoxicity in rats.
    Sun SY, An CN, Pu XP.
    Brain Res Bull; 2012 Sep 01; 88(6):609-16. PubMed ID: 22664331
    [Abstract] [Full Text] [Related]

  • 37. DJ-1 expression modulates astrocyte-mediated protection against neuronal oxidative stress.
    Mullett SJ, Di Maio R, Greenamyre JT, Hinkle DA.
    J Mol Neurosci; 2013 Mar 01; 49(3):507-11. PubMed ID: 23065353
    [Abstract] [Full Text] [Related]

  • 38. Dopaminergic neuroprotective effects of rotigotine via 5-HT1A receptors: Possibly involvement of metallothionein expression in astrocytes.
    Isooka N, Miyazaki I, Kikuoka R, Wada K, Nakayama E, Shin K, Yamamoto D, Kitamura Y, Asanuma M.
    Neurochem Int; 2020 Jan 01; 132():104608. PubMed ID: 31765686
    [Abstract] [Full Text] [Related]

  • 39. Hexokinase II gene transfer protects against neurodegeneration in the rotenone and MPTP mouse models of Parkinson's disease.
    Corona JC, Gimenez-Cassina A, Lim F, Díaz-Nido J.
    J Neurosci Res; 2010 Jul 01; 88(9):1943-50. PubMed ID: 20143419
    [Abstract] [Full Text] [Related]

  • 40. Regulation of astrocyte inflammatory responses by the Parkinson's disease-associated gene DJ-1.
    Waak J, Weber SS, Waldenmaier A, Görner K, Alunni-Fabbroni M, Schell H, Vogt-Weisenhorn D, Pham TT, Reumers V, Baekelandt V, Wurst W, Kahle PJ.
    FASEB J; 2009 Aug 01; 23(8):2478-89. PubMed ID: 19276172
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.